Hepatitis C virus-related mixed cryoglobulinemia: Is genetics to blame?

World Journal of Gastroenterology

Volumn 19, Issue 47, 2013, Pages 8910-8915

  Gragnani, Laura ^a   Fognani, Elisa ^a   Piluso, Alessia ^a   Zignego, Anna Linda ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Genetics; Hepatitis C virus; Host pathogenetic factors; Mixed cryoglobulinemia; Viral pathogenetic factors

Indexed keywords

B CELL ACTIVATING FACTOR; CD16 ANTIGEN; CYTOKINE; FAS ANTIGEN; FAS LIGAND; FC RECEPTOR; FC RECEPTOR IIA; FC RECEPTOR IIB; FIBRONECTIN; GLYCOPROTEIN E2; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 28B; RITUXIMAB;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CRYOGLOBULINEMIA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MUTATION; NONHODGKIN LYMPHOMA; NONHUMAN; PROTEIN POLYMORPHISM;

GENETICS; HEPATITIS C VIRUS; HOST PATHOGENETIC FACTORS; MIXED CRYOGLOBULINEMIA; VIRAL PATHOGENETIC FACTORS;

CRYOGLOBULINEMIA; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS C; HUMANS; INDIVIDUALIZED MEDICINE; PHENOTYPE; PROGNOSIS; RISK FACTORS;

EID: 84890921892     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i47.8910     Document Type: Article

References (44)

1. Zignego AL, Giannini C, Gragnani L. HCV and lympho-proliferation. Clin Dev Immunol 2012; 2012: 980942PMID: 22852020 DOI: 10.1155/2012/980942]
2. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boi-occhi M, Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160: 3594-3601[PMID: 9531323]
3. Zignego AL, Gragnani L, Giannini C, Laff G. The hepatitis C virus infection as a systemic disease. Intern Emerg Med 2012; 7 Suppl 3: S201-S208[PMID: 23073858 DOI: 10.1007/ s11739-012-0825-6]
4. Ferri C, Zignego AL, Bombardieri S, La Civita L, Longom-bardo G, Monti M, Lombardini F, Greco F, Pasero G. Etio-pathogenetic role of hepatitis C virus in mixed cryoglobu-linemia, chronic liver diseases and lymphomas. Clin Exp Rheumatol 1995; 13 Suppl 13: S135-S140[PMID: 8730494]
5. Ferri C, Longombardo G, La Civita L, Greco F, Lombardini F, Cecchetti R, Cagianelli MA, Marchi S, Monti M, Zignego AL. Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med 1994; 236: 31-36[PMID: 8021570]
6. Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi ME, Di Pietro E, La Villa G, Laff G, Gentilini P. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-580[PMID: 12353944]
7. Bianchettin G, Bonaccini C, Oliva R, Tramontano A, Civi-dini A, Casato M, Merlini G, Silini E, Mondelli MU. Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls. J Virol 2007; 81: 4564-4571[PMID: 17314160]
8. Gragnani L, Piluso A, Giannini C, Caini P, Fognani E, Monti M, Petrarca A, Ranieri J, Razzolini G, Froio V, Laff G, Zigne-go AL. Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors. Arthritis Rheum 2011; 63: 1446-1451[PMID: 21538321 DOI: 10.1002/art.30274]
9. Peveling-Oberhag J, Crisman G, Schmidt A, Döring C, Lucioni M, Arcaini L, Rattotti S, Hartmann S, Piiper A, Hof-mann WP, Paulli M, Küppers R, Zeuzem S, Hansmann ML. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia 2012; 26: 1654-1662[PMID: 22307176 DOI: 10.1038/leu.2012.29]
10. Fognani E, Giannini C, Piluso A, Gragnani L, Monti M, Caini P, Ranieri J, Urraro T, Triboli E, Laff G, Zignego AL. Role of microRNA profle modifcations in hepatitis C virus-related mixed cryoglobulinemia. PLoS One 2013; 8: e62965[PMID: 23650540 DOI: 10.1371/journal.pone.0062965]
11. Gragnani L, Fognani E, Piluso A, Zignego AL. Hepatitis C-associated B-cell non-Hodgkin lymphomas: The emerging role of miRNA-26b. J Hepatol 2013; 59: 1362-1363[PMID: 23978716]
12. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-3053[PMID: 7949176]
13. Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Nevens F, Durez P, Treille S, Adler M, Desmet V. Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-relat-ed syndrome. J Med Virol 1994; 44: 266-271[PMID: 7531756]
14. Sinico RA, Ribero ML, Fornasieri A, Renoldi P, Zhou J, Fa-sola M, Portera G, Arrigo G, Gibelli A, D'Amico G. Hepatitis C virus genotype in patients with essential mixed cryoglobu-linaemia. QJM 1995; 88: 805-810[PMID: 8542265]
15. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996; 25: 427-432[PMID: 8912140]
16. Gerotto M, Dal Pero F, Loffreda S, Bianchi FB, Alberti A, Lenzi M. A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2. Blood 2001; 98: 2657-2663[PMID: 11675335]
17. Hofmann WP, Herrmann E, Kronenberger B, Merkwirth C, Welsch C, Lengauer T, Zeuzem S, Sarrazin C. Association of HCV-related mixed cryoglobulinemia with specific mutational pattern of the HCV E2 protein and CD81 expression on peripheral B lymphocytes. Blood 2004; 104: 1228-1229[PMID: 15294858 DOI: 10.1182/blood-2004-02-0644]
18. Rigolet A, Cacoub P, Schnuriger A, Vallat L, Cahour A, Ghillani P, Davi F, Benhamou Y, Piette JC, Thibault V. Genetic heterogeneity of the hypervariable region I of Hepatitis C virus and lymphoproliferative disorders. Leukemia 2005; 19: 1070-1076[PMID: 15843828]
19. Pozzato G, Burrone O, Baba K, Matsumoto M, Hijiiata M, Ota Y, Mazzoran L, Baracetti S, Zorat F, Mishiro S, Efremov DG. Ethnic difference in the prevalence of monoclonal B-cell proliferation in patients affected by hepatitis C virus chronic liver disease. J Hepatol 1999; 30: 990-994[PMID: 10406175]
20. Migliorini P, Bombardieri S, Castellani A, Ferrara GB. HLA antigens in essential mixed cryoglobulinemia. Arthritis Rheum 1981; 24: 932-936[PMID: 6942841]
21. Ossi E, Bordin MC, Businaro MA, Marson P, Bonadonna P, Chiaramonte M, Boin F, Valenti MT, Fagiolo U. HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. Clin Exp Rheumatol 1995; 13 Suppl 13: S91-S93[PMID: 8730485]
22. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, Lampis R, Cao A, Lai ME, De Virgiliis S. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatology 1996; 24: 1338-1341[PMID: 8938157]
23. Lenzi M, Frisoni M, Mantovani V, Ricci P, Muratori L, Fran-cesconi R, Cuccia M, Ferri S, Bianchi FB. Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998; 91: 2062-2066[PMID: 0009490691]
24. Hwang SJ, Chu CW, Huang DF, Lan KH, Chang FY, Lee SD. Genetic predispositions for the presence of cryoglobu-linemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 2002; 59: 31-37[PMID: 11972876]
25. Amoroso A, Berrino M, Canale L, Cornaglia M, Guarrera S, Mazzola G, Savoldi S, Scolari F, Sällberg M, Clementi M, Gabrielli A. Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryo-globulinemia type II after hepatitis C virus infection? J Hepa-tol 1998; 29: 36-44[PMID: 9696490]
26. Cacoub P, Renou C, Kerr G, Hüe S, Rosenthal E, Cohen P, Kaplanski G, Charlotte F, Thibault V, Ghillani P, Piette JC, Caillat-Zucman S. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 2001; 44: 2118-2124[PMID: 11592376]
27. De Re V, Caggiari L, Monti G, Libra M, Spina M, Dolcetti R, De Zorzi M, Racanelli V, Crovatto M, Toffoli G. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia. Tissue Antigens 2010; 75: 127-135 [PMID: 20002609 DOI: 10.1111/ j.1399-0039.2009.01414.x]
28. Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonel-li A. Cytokines and HCV-related disorders. Clin Dev Immunol 2012; 2012: 468107[PMID: 22611419 DOI: 10.1155/2012/468107]
29. Persico M, Capasso M, Persico E, Masarone M, Renzo Ad, Spano D, Bruno S, Iolascon A. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 2006; 45: 779-785[PMID: 17049666]
30. De Vita S, Quartuccio L, Fabris M. Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? Autoimmun Rev 2008; 8: 95-99[PMID: 18589005]
31. Toubi E, Gordon S, Kessel A, Rosner I, Rozenbaum M, Shoenfeld Y, Zuckerman E. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 2006; 27: 134-139[PMID: 17029886]
32. Fabris M, Quartuccio L, Sacco S, De Marchi G, Pozzato G, Mazzaro C, Ferraccioli G, Migone TS, De Vita S. B-Lympho-cyte stimulator (BLyS) up-regulation in mixed cryoglobu-linaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford) 2007; 46: 37-43[PMID: 16735452]
33. Sène D, Limal N, Ghillani-Dalbin P, Saadoun D, Piette JC, Cacoub P. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) 2007; 46: 65-69[PMID: 16782735]
34. Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 2006; 24: 983-987[PMID: 16432079]
35. Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Toku-naga K. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythema-tosus and rheumatoid arthritis. Genes Immun 2002; 3: 424-429[PMID: 12424625]
36. Giannini C, Gragnani L, Piluso A, Caini P, Petrarca A, Monti M, Laffi G, Zignego AL. Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? Blood 2008; 112: 4353-4354[PMID: 18988879]
37. Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7: 715-725[PMID: 17703228]
38. Vassilopoulos D, Younossi ZM, Hadziyannis E, Boparai N, Yen-Lieberman B, Hsi E, Villa-Forte A, Ball E, Kimberly RP, Calabrese LH. Study of host and virological factors of patients with chronic HCV infection and associated laboratory or clinical autoimmune manifestations. Clin Exp Rheumatol 2003; 21: S101-S111[PMID: 14740435]
39. Bertolo F, De Vita S, Dolcetti R, Carbone A, Ferraccioli GF, Bartoli E, Boiocchi M. Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjögren's syndrome and type II mixed cryoglobulinemia. Clin Exp Rheumatol 1999; 17: 339-342[PMID: 10410268]
40. Fabris M, Quartuccio L, Salvin S, Pozzato G, De Re V, Maz-zaro C, Ferri C, Baldini C, De Vita S. Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. Ann Rheum Dis 2008; 67: 80-83[PMID: 17526550]
41. Terrier B, Jehan F, Munteanu M, Geri G, Saadoun D, Sène D, Poynard T, Souberbielle JC, Cacoub P. Low 25-hydroxyvi-tamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection. Rheumatology (Oxford) 2012; 51: 2083-2090[PMID: 22908327 DOI: 10.1093/rheumatology/kes209]
42. Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Has-sler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J Hepatol 2011; 54: 887-893[PMID: 21145801 DOI: 10.1016/ j.jhep.2010.08.036]
43. Terrier Benjamin JF, Monteanu Mona, Geri Guillaume, Saa-doun David, Sene Damien, Poynard Thierry. Serum Vitamin D Status And Polymorphisms In Vitamin D Metabolism-Related Genes In Chronic Hepatitis C Virus Infection With Extra-Hepatic Manifestations. Proceedings of the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. Chicago: Arthritis and Rheumatism, 2011: 2620
44. Piluso A, Giannini C, Fognani E, Gragnani L, Caini P, Monti M, Petrarca A, Ranieri J, Urraro T, Triboli E, Laff G, Zignego AL. Value of IL28B genotyping in patients with HCV-related mixed cryoglobulinemia: results of a large, prospective study. J Viral Hepat 2013; 20: e107-e114[PMID: 23490377 DOI: 10.1111/jvh.12017]